Monday, May 30th, 2016

About the Osteoarthritis Pain Drugs Market 
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age). The exact etiology of osteoarthritis is not well understood, but is believed to be an outcome of mechanical and molecular events in the affected joint. Increasing age, obesity, overuse of the joint, weak thigh muscles, and genetics are some of the common risk factors. Treatment is given depending upon the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise. 
Technavio’s analysts forecast the global osteoarthritis pain drugs market to grow at a CAGR of 8.38% during the period 2016-2020.

Complete report details @                                         


Covered in this report 
The report covers the present scenario and the growth prospects of the global osteoarthritis pain drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat osteoarthritis pain. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.

The market is divided into the following segments based on geography: 
• Americas 

The report, Global Osteoarthritis Pain Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Abbott Laboratories 
• Johnson & Johnson 
• Novartis International 
• Pfizer

Request a sample report @

Other prominent vendors 
• AbbVie 
• Abiogen Pharma 
• Afferent Pharmaceuticals 
• Astellas Pharma 
• BioDelivery Sciences International 
• Crystal Genomics 
• Cytori Therapeutics 
• Daiichi Sankyo 
• Eli Lilly 
• Endo Pharmaceuticals Holdings 
• Horizon Pharma 
• iCeutica 
• Iroko Pharmaceuticals 
• Merck 
• Nuvo Research 
• Regeneron Pharmaceuticals 
• Sanofi 
• SantoSolve 
• Techfields Pharma 
• Winston Pharmaceuticals 
• Yooyoung Pharmaceutical 
• Zynerba Pharmaceuticals

Market driver 
• Significant unmet medical needs 
• For a full, detailed list, view our report

Market challenge 
• Preference for alternative therapies 
• For a full, detailed list, view our report

Market trend 
• Emergence of new treatments 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @

Table of content

PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Assumptions 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
• Key buying criteria 
PART 05: Disease overview 
• Understanding osteoarthritis 
• Etiology and pathophysiology 
• Risk factors 
• Signs and symptoms 
• Diagnosis 
• Disease management 
• Surgical treatment 
• Epidemiology 
• Economic burden of osteoarthritis 
PART 06: Pipeline portfolio 
• Information on pipeline candidates 
• Ampion 
• Tanezumab 
• Zilretta (FX006) 
• Fasinumab 
• IP 880 
• SoluMatrix Naproxen 
• ABT-981 
• AF-219 
• ASP7962 
PART 07: Osteoarthritis pain drugs: Clinical trials 
PART 08: Opportunities for research in osteoarthritis 

• Gaps between current research and possible research issues 
• Challenges for vendors involved in osteoarthritis drug development 
PART 09: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 
PART 10: Market segmentation by drug class 
• Opioids 
• Viscosupplements 
• Corticosteroids 
• Others 
• Global NSAIDs market 
• Global opioids market 
• Global viscosupplements market 
• Global corticosteroids market 
PART 11: Market segmentation by ROA 
• Oral 
• Parenteral 
• Topical 
PART 12: Market segmentation by dosage form 
• Solid 
• Liquid 
• Semi-solid 
PART 13: Geographical segmentation 
• Osteoarthritis pain drugs market in Americas 
• Osteoarthritis pain drugs market in US 
• Osteoarthritis pain drugs market in EMEA 
• Osteoarthritis pain drugs market in APAC 
PART 14: Market drivers 
• Significant unmet medical needs 
• Promising drug pipeline 
• Increase in prevalence of osteoarthritis and obesity 
PART 15: Impact of drivers 
PART 16: Market challenges 

• Preference for alternative therapies 
• Loss of patent exclusivity of branded therapies 
• Adverse effects of drugs 
PART 17: Impact of drivers and challenges 
PART 18: Market trends 

• Emergence of new treatments 
• Use of off-label drugs 
• Strategic alliances 
PART 19: Vendor landscape 
• Competitive scenario 
• Abbott Laboratories 
• Johnson & Johnson 
• Novartis 
• Pfizer 
• Other prominent vendors 
PART 20: Upcoming vendors with novel approaches 
• Ampio Pharmaceuticals 
• Flexion Therapeutics 
• Kitov Pharmaceuticals 
PART 21: Appendix 
• List of abbreviations 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          



Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Osteoarthritis Pain market trend, Osteoarthritis Pain market segmentation, Osteoarthritis Pain market analysis, Osteoarthritis Pain market parameters, Osteoarthritis Pain industry forecast, Osteoarthritis Pain market size, Osteoarthritis Pain market share




More Formats

View QR Code